Dr RR Baliga's "Got Knowledge Doc" Podkast

Neutropenic Fever + MCQ

from chapter titled

Emergencies in Hematology and Oncology

in

Baliga's Textbook of Internal Medicine

available at

MasterMedFacts.com

authored by

Thorvardur Halfdanarson,MD

Professor of Oncology

Mayo Clinic, Rochester, MN

&

Eric Engelman, MD

Clinical Hematologist/Oncologist

Dubuque, Iowa

Not Medical Advice or Opinion

🎧 Dr RR Baliga's IGot Knowledge Doc?" Podkasts for Physicians: MUST KNOW FACTs about AHA Scientific Statement on Cardio-Oncology: Vascular and Metabolic Perspectives

Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association. Circulation 2019;Feb 21

Campia U, Moslehi JJ, Amiri-Kordestani L, et al., on behalf of the American Heart Association Council on Peripheral Vascular Disease; Council on Arteriosclerosis, Thrombosis and Vascular Biology; and Council on Cardiovascular and Stroke Nursing.

Not Medical Advice or Opinion

Neutrophil Extracellular Traps (NETs) as Biomarkers and Therapeutic Targets?

Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians

References

Yang L, Liu Q, Zhang X, et al. DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25 [published online ahead of print, 2020 Jun 11]. Nature. 2020

Thålin C, et al. Neutrophil Extracellular Traps: Villains and Targets in Arterial, Venous, and Cancer-Associated Thrombosis. Arterioscler Thromb Vasc Biol. 2019;39(9):1724-1738.

Döring Y, Libby P, Soehnlein O. Neutrophil Extracellular Traps Participate in Cardiovascular Diseases: Recent Experimental and Clinical Insights. Circ Res. 2020;126(9):1228-1241.

Dr RR Baliga's Internal Medicine Podcasts for Physicians: MUST KNOW FACTs about Neoplasia and The Heart

Neoplasia and the HeartPathological Review of Effects With Clinical and Radiological Correlation

Dr RR Baliga's 'Got Knowledge Doc?' PodKasts for Physicians| Is Cardiac Magnetic Resonance Imaging Useful in Chemotherapy Induced Cardiotoxicity

1. Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis European Heart Journal, Volume 41, Issue 18, 7 May 2020, Pages 1733–1743,
2. Immune checkpoint inhibitor cardiotoxicity: what can we learn from real life data on CMR as a diagnostic tool? European Heart Journal, Volume 41, Issue 18, 7 May 2020, Pages 1744–1746
3. Can Quantitative CMR Tissue Characterization Adequately Identify Cardiotoxicity During Chemotherapy? Impact of Temporal and Observer Variability. JACC Cardiovasc Imaging 2020;13:951-962.

🎧 Dr RR Baliga's Internal Medicine Podcasts for Physicians: MUST KNOW FACTs about Androgen Deprivation Therapy & Cardiovascular Disease.

Not Medical Advice or Opinion

Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians| CARAVAGGIO Trial: Is Apixaban safe and efficacious in Cancer Venous Thromboembolism?-NEJM April 2020 | Not Medical Advice or Opinion

1. Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer N Engl J Med 2020; 382:1599-1607
2. Anticoagulant Therapy for Venous Thromboembolism in Cancer N Engl J Med 2020; 382:1650-1652
3. Tukaye DN, Brink H, Baliga R. Venous thromboembolism in cancer patients: risk assessment, prevention and management. Future Cardiol. 2016;12(2):221‐235. doi:10.2217/fca.15.87
4. Arcopinto M, Cella CA, Wesolowski R, et al. Primary prevention of cancer-related thrombosis: special focus on ambulatory patients. Int J Cardiol. 2014;173(3):583‐584. doi:10.1016/j.ijcard.2014.03.109

Therapy of Transthyretin Cardiomyopathy

Dr Baliga's MUST KNOW FACTS PODCASTS FOR PHYSICIANS

derived from a chapter authored by

Taimur Sher, MD

Faculty Hematologist & Associate Professor,

Mayo Clinic, Jacksonville

&

Moire A Gertz, MD

Emeritus Chair & Consult Hematologist,

Mayo Clinic, Rochester, MN

in

Color Atlas and Synopsis of Heart Failure

edited by RR Baliga, MD

McGraw Hill Education

-

Not Medical Advice or Opinion

Cardiovascular Events with CHOP/RCHOP in Non-Hogkin's -

Dr RR Baliga's 'Got Knowledge Doc' PODCASTS for Physicians

https://doi.org/10.1016/S2352-3026(20)30031-4

Not Medical Advice or Opinion